|
|||||
|
|
Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug‐naïve patients with type 2 diabetes: a randomized,double‐blind, 6‐month study |
|
| Authors: | R. E. Pratley P. Fleck C. Wilson |
| Affiliation: | 1. Florida Hospital, Sanford Burnham Medical Research Institute, , Orlando, FL, USA;2. Takeda Development Center Americas, Inc., , Deerfield, IL, USA |
| Abstract: | |
| Keywords: | alogliptin coadministration combination therapy dipeptidyl peptidase‐4 inhibitor DPP‐4 metformin monotherapy T2DM type 2 diabetes mellitus |